Pfizer insider trading
Health Care · Strong buyingShare price and insider trades
Valuation, profit and volume
Summary
Over the past 12 months, 3 Pfizer insiders reported open-market purchases totaling $3.0M, while 1 insider reported sales totaling $135K. The most recent cluster buy began on Aug 5, 2026, when 3 insiders bought a combined $3.0M. 0 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
News and SEC events
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales. 28 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 12SEC | Albert BourlaCEO, Chair | Buy | 38,000 | $26.34 | $1.0M | +4.1% | — |
| Aug 6SEC | Jennifer B. DamicoSvp & Controller | Sell | 3,278 | $25.40 | $83K | +7.9% | — |
| Aug 5SEC | Ronald E BlaylockDirector | Buy | 39,231 | $25.46 | $999K | +7.7% | — |
| Aug 5SEC | Mortimer J BuckleyDirector | Buy | 37,632 | $25.52 | $960K | +7.4% | — |
| Jun 10SEC | Jennifer B. DamicoSvp & Controller | Sell | 2,000 | $25.70 | $51K | +6.7% | — |
Insiders at Pfizer
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Albert BourlaCEO, Chair | $1.0M | — | Aug 12, 2026 | — |
| Ronald E BlaylockDirector | $999K | — | Aug 5, 2026 | — |
| Mortimer J BuckleyDirector | $960K | — | Aug 5, 2026 | — |
| Jennifer B. DamicoSvp & Controller | — | $135K | Aug 6, 2026 | — |
| Douglas M LanklerPresident | — | — | Feb 27, 2026 | — |
| Lidia FonsecaPresident | — | — | Feb 27, 2026 | — |
| Payal SahniPresident | — | — | Feb 27, 2026 | — |
| Michael McdermottPresident | — | — | Feb 27, 2026 | — |
| Christoffel BoshoffPresident | — | — | Feb 27, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about PFE insiders
Are Pfizer insiders buying PFE stock?
In the past 12 months, 3 insiders reported open-market purchases of PFE worth $3.0M. The latest was CEO, Chair Albert Bourla bought $1.0M of PFE at $26.34 — first open-market purchase in our records.
Are Pfizer insiders selling PFE stock?
1 insiders reported sales worth $135K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.